epigallocatechin gallate has been researched along with Carcinoma, Transitional Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, WA; Chen, YJ; Ke, HL; Kuo, PL; Lee, HY; Li, WM; Wu, WJ | 1 |
| Gomez, MA; Hampton, JA; Keck, RW; Kemberling, JK; Selman, SH | 1 |
| Chuang, JC; Jones, PA; Kwan, JM; Li, TW; Liang, G; Yang, AS; Yoo, CB | 1 |
3 other study(ies) available for epigallocatechin gallate and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Effects of Epigallocatechin Gallate (EGCG) on Urinary Bladder Urothelial Carcinoma-Next-Generation Sequencing and Bioinformatics Approaches.
Topics: Anticarcinogenic Agents; Carcinoma, Transitional Cell; Catechin; Cell Line, Tumor; Computational Biology; High-Throughput Nucleotide Sequencing; Humans; MicroRNAs; Signal Transduction; Urinary Bladder Neoplasms | 2019 |
Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Transitional Cell; Catechin; Dose-Response Relationship, Drug; Free Radical Scavengers; Rats; Rats, Inbred F344; Tea; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2003 |
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Transitional Cell; Catechin; Cell Line, Tumor; Colorectal Neoplasms; Cytidine; Decitabine; Deoxycytidine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Female; Gene Silencing; HT29 Cells; Humans; Hydralazine; Male; Procainamide; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction | 2005 |